Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post-chemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00407251
What this trial is testing

Study of Patupilone in Prostate Cancer Patients Who Progress After Hormone Therapy and Docetaxel Chemotherapy

Who this might be right for
Hormone Refractory Prostate Cancer
British Columbia Cancer Agency 73
Not applicableUnknownNCT04250129
What this trial is testing

SENTINEL LYMPH NODE BIOPSY AFTER NEOADJUVANT CHEMOTHERAPY

Who this might be right for
Sentinel Lymph Node
Federation of Breast Diseases Societies 500
Large-scale testing (Phase 3)UnknownNCT00482222
What this trial is testing

Combination Chemotherapy With or Without Cetuximab Before and After Surgery in Treating Patients With Resectable Liver Metastases Caused By Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
University of Southampton 340
Testing effectiveness (Phase 2)UnknownNCT04547829
What this trial is testing

Safety and Efficacy of PEG-rhG-CSF in Preventing Neutropenia in Children With Tumor After Chemotherapy

Who this might be right for
Pediatric Cancer
Sun Yat-sen University 108
Large-scale testing (Phase 3)Study completedNCT01864746
What this trial is testing

Palbociclib in Addition to Standard Endocrine Treatment in Hormone Receptor Positive Her2 Normal Patients With Residual Disease After Neoadjuvant Chemotherapy and Surgery

Who this might be right for
Breast CancerHormonreceptor PositiveHer2-normal+2 more
GBG Forschungs GmbH 1,250
Large-scale testing (Phase 3)Ended earlyNCT00169169
What this trial is testing

Efficacy Study of Rituximab After ASCT in High-Risk Diffuse Large B-Cell Lymphoma

Who this might be right for
CD20-Positive Large B-Cell Lymphoma
Lymphoma Study Association 430
Large-scale testing (Phase 3)Active Not RecruitingNCT06382129
What this trial is testing

A Study Comparing BL-B01D1 With Docetaxel in Patients With Unresectable Locally Advanced or Metastatic EGFR Wild-type Non-small Cell Lung Cancer(PANKU-Lung02)

Who this might be right for
Non-small Cell Lung Cancer
Sichuan Baili Pharmaceutical Co., Ltd. 698
Not applicableActive Not RecruitingNCT04711330
What this trial is testing

Response and Toxicity Prediction by Microbiome Analysis After (Concurrent) Chemoradiotherapy

Who this might be right for
Non Small Cell Lung Cancer Stage IIIImmunotherapy
Leiden University Medical Center 126
Not applicableActive Not RecruitingNCT03418844
What this trial is testing

Living After a Rare Cancer of the Ovary: Chronic Fatigue, Quality of Life and Late Effects of Chemotherapy

Who this might be right for
Germ Cell TumorSex Cord Stromal TumorMalignant Non-epithelial Ovarian Tumors
Centre Francois Baclesse 268
Testing effectiveness (Phase 2)Ended earlyNCT02921737
What this trial is testing

TAS-102 (Lonsurf) in Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma Post First Line Chemotherapy (UF-STO-PANC-003)

Who this might be right for
Pancreatic Cancer
University of Florida 7
Testing effectiveness (Phase 2)Ended earlyNCT00034372
What this trial is testing

Multicenter Clinical Trial of Intravenous OvaRex MAb-B43.13 as Post-Chemotherapy Consolidation for Ovarian Carcinoma

Who this might be right for
Ovarian Neoplasms
Unither Pharmaceuticals 102
Testing effectiveness (Phase 2)Ended earlyNCT00863330
What this trial is testing

Laboratory-Treated Autologous Lymphocytes and Aldesleukin After Cyclophosphamide and Fludarabine in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
Wake Forest University Health Sciences 14
Testing effectiveness (Phase 2)Study completedNCT00377429
What this trial is testing

Safety and Efficacy Study of Catumaxomab to Treat Ovarian Cancer After a Complete Response to Chemotherapy

Who this might be right for
Ovarian Cancer
Neovii Biotech 47
Large-scale testing (Phase 3)Looking for participantsNCT06092957
What this trial is testing

Reduced-dose RT With/Without CCT Versus Standard CCRT for High-risk LANPC Who Achieved CR Post Induction Chemotherapy

Who this might be right for
Nasopharyngeal CarcinomaDe-escalation Therapy
Sun Yat-sen University 504
Testing effectiveness (Phase 2)Study completedNCT00033657
What this trial is testing

Radiation Therapy and Chemotherapy Before and After Surgery in Treating Patients With Esophageal Cancer

Who this might be right for
Esophageal CancerGastric Cancer
Eastern Cooperative Oncology Group 97
Testing effectiveness (Phase 2)Study completedNCT00028730
What this trial is testing

Total-Body Irradiation and Chemotherapy Followed By Donor Bone Marrow Transplant in Treating Young Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndromes+1 more
Memorial Sloan Kettering Cancer Center 25
Not applicableUnknownNCT05628272
What this trial is testing

MNCs for Bone Marrow Failure After Malignant Diseases Children Chemotherapy

Who this might be right for
Cord
Qianfoshan Hospital 20
Large-scale testing (Phase 3)Looking for participantsNCT07152405
What this trial is testing

BL-M07D1 Versus Investigator's Choice of Chemotherapy in Patients With HER2-positive Locally Advanced or Metastatic Gastric or Gastro-esophageal Junction Adenocarcinoma

Who this might be right for
Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma
Sichuan Baili Pharmaceutical Co., Ltd. 490
Large-scale testing (Phase 3)UnknownNCT00442637
What this trial is testing

Maintenance Treatment Versus Observation After Induction in Advanced Colorectal Carcinoma

Who this might be right for
Colorectal Cancer Metastatic
Dutch Colorectal Cancer Group 635
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07381777
What this trial is testing

XELOX Plus DoSTARlimab Versus XELOX Alone as Consolidation Treatment After Standard Chemoradiation in pMMR/MSS or MSI-Low Locally Advanced Rectal Cancer (LARC) Patients

Who this might be right for
Locally Advanced Rectal Cancer (LARC)
Gruppo Oncologico Italiano di Ricerca Clinica 270
Next Page